US Patent 9365654 Anti-TrkA antibodies, derivatives and uses thereof
Patent 9365654 was granted and assigned to Rottapharm on June, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9365654 Anti-TrkA antibodies, derivatives and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
